<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert W Hostoffer, DO, LhD, MSMed, MBA, FACOP, FAAP, FACOI, FCCP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jordan S Orange, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anna M Feldweg, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 05, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Selective immunoglobulin A (IgA) deficiency (sIgAD; MIM 137100) may be defined as the isolated deficiency of serum IgA (ie, in the setting of normal serum levels of immunoglobulin G [IgG] and immunoglobulin M [IgM]) in an individual older than four years of age in whom other causes of hypogammaglobulinemia have been excluded [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         The clinical manifestations of sIgAD are variable, ranging from no symptoms to recurrent infections and autoimmune disease. This topic will review the epidemiology, clinical manifestations, diagnosis, and pathophysiology of sIgAD. The management and prognosis of patients with this disorder are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3936.html" rel="external">
          "Selective IgA deficiency: Management and prognosis"
         </a>
         .)
        </p>
        <p>
         The structure and normal functions of IgA are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/89914.html" rel="external">
          "Structure and biologic functions of IgA"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          NORMAL BIOLOGY OF IgA
         </span>
         <span class="headingEndMark">
          —
         </span>
         IgA accounts for more than 70 percent of total immunoglobulin in the body. The normal functions of IgA are mentioned briefly here and discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/89914.html" rel="external">
          "Structure and biologic functions of IgA"
         </a>
         .)
        </p>
        <p>
         IgA exists in two distinct forms:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Monomeric IgA in the serum
         </strong>
         – This type of IgA interacts with the phagocytic arm of the immune system. IgA molecules bind foreign antigens through their Fab portions, while the Fc portion binds to the Fc-alpha receptor (CD89) located on the cell surface of neutrophils, eosinophils, and macrophages [
         <a href="#rid2">
          2,3
         </a>
         ]. IgA binding to the receptor initiates ingestion and destruction of the microorganism by the phagocyte. (See
         <a class="medical medical_review" href="/z/d/html/3970.html" rel="external">
          "Overview of therapeutic monoclonal antibodies"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dimeric secretory IgA in secretions
         </strong>
         – This form of IgA is found in saliva, milk, colostrum, tears, and mucosal secretions from the respiratory tract, genitourinary tract, and prostate. It is called secretory IgA and is believed to be important in mucosal immunity. Its actions include coating of microbes to prevent adherence to epithelial cells and neutralization of microbial toxins, as well as dampening of inflammatory pathways that could lead to autoimmune processes. In addition, secretory IgA promotes intestinal homeostasis between the host and commensal bacteria by regulating bacterial communities, favoring commensal organisms in biofilms, and preventing pathogen overgrowth.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          PATHOPHYSIOLOGY OF IgA DEFICIENCY
         </span>
         <span class="headingEndMark">
          —
         </span>
         sIgAD is believed to be a heterogeneous disorder that probably arises through several pathogenic mechanisms. The precise molecular defects are unknown. However, most humoral immunodeficiencies arise from either defects in B cells or defective interactions between B and T cells. A brief review of normal B cell development and antibody production is helpful in understanding the theories of pathogenesis.
        </p>
        <p>
         Despite the apparent importance of IgA in mucosal immunity, the vast majority of patients with IgA deficiency do not experience more frequent or severe infections or overt autoimmune disease. This disconnect between the presumed role of IgA and clinical observations of IgA deficiency is probably explained by the presence of redundant immunologic mechanisms that protect the host. For example, secretory IgM may perform many of the same functions and may compensate for lack of IgA in normal neonates and in patients with IgA deficiency [
         <a href="#rid4">
          4
         </a>
         ]. For example, most IgA-deficient patients (although not all [
         <a href="#rid5">
          5
         </a>
         ]) appear to have increased production of secretory IgM [
         <a href="#rid6">
          6,7
         </a>
         ], and IgA and IgM have evolutionary, structural, and functional similarities [
         <a href="#rid8">
          8-10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          B cells in IgA deficiency
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with sIgAD, B cells expressing surface IgA are present but appear to be developmentally blocked. Theoretically, the defect resides after the surface coexpression of IgM and IgA, although this has not been established with certainty. Based on animal studies, the failure of B cells to terminally differentiate into plasma cells that secrete IgA may be due to the lack of effects from various cytokines, such as interleukin (IL) 21, IL-4, IL-6, IL-7, or IL-10, although other mechanisms have also been proposed [
         <a href="#rid11">
          11-17
         </a>
         ]. B cells found in IgA-deficient patients show a decrease in the frequency of switched memory B cells, transitional cells, and plasmablasts, as well as an increase in CD21
         <sup>
          low
         </sup>
         CD38
         <sup>
          low
         </sup>
         subset [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H17792057">
         <span class="h2">
          T regulatory cells
         </span>
         <span class="headingEndMark">
          —
         </span>
         The mean percentage of T regulatory cells (CD4
         <sup>
          +
         </sup>
         , CD25
         <sup>
          high
         </sup>
         , FoxP3
         <sup>
          +
         </sup>
         T cells) was significantly lower in 26 children (ages 4 to 17 years) with sIgAD compared with normal controls [
         <a href="#rid19">
          19
         </a>
         ]. When patients with sIgAD were classified into two groups based on the percentages of T regulatory cells, a greater proportion of those with lower T regulatory cells had autoimmune disorders, pneumonia, and evidence of class-switching defects. These findings await replication and evaluation in other age groups.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Genetic factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         IgA deficiency is associated with several types of genetic abnormalities, although none are known to be causative, and there may be other, more relevant defects that have not been identified.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Associated molecular defects
         </strong>
         – The first genetic defect to be identified in patients with sIgAD was a mutation in the tumor necrosis factor (TNF) receptor family member "transmembrane activator and calcium-modulator and cyclophilin ligand interactor" (TACI), a molecule that mediates isotype-switching in B cells. However, TACI mutations/polymorphisms have been identified in only a small subset of patients with sIgAD, as well as in some patients with common variable immunodeficiency (CVID), and it is not clear that these mutations/polymorphisms are directly related to pathogenesis [
         <a href="#rid20">
          20
         </a>
         ]. B cells in these patients expressed TACI but did not produce IgG and IgA in response to the TACI ligand, suggesting impaired isotype switching [
         <a href="#rid21">
          21,22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3904.html" rel="external">
          "Pathogenesis of common variable immunodeficiency"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Large chromosomal abnormalities
         </strong>
         – There are conflicting findings concerning the presence or absence of large chromosomal abnormalities. Some studies have reported abnormalities involving chromosomes 16 and 18, while other studies have not found consistent abnormalities within IgA-deficient families [
         <a href="#rid23">
          23-31
         </a>
         ]. Long- or short-arm deletion and ring formation have been described in some patients who are also intellectually disabled and exhibit additional dysmorphic features [
         <a href="#rid28">
          28
         </a>
         ]. These findings are probably not relevant to asymptomatic IgA-deficient patients.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Major histocompatibility complex (MHC) loci associations
         </strong>
         – Associations have also been identified between sIgAD and several genes of the MHC [
         <a href="#rid31">
          31-39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Abnormalities in genes associated with autoimmunity
         </strong>
         – Genome-wide association studies revealed an association between sIgAD and genetic variants in the genes for interferon-induced helicase C domain-containing protein (
         <em>
          IFIH1
         </em>
         ) and for C-type lectin domain family 16 (
         <em>
          CLEC16A
         </em>
         ) [
         <a href="#rid40">
          40
         </a>
         ]. Mutations in these loci are also associated with autoimmune disorders [
         <a href="#rid38">
          38
         </a>
         ]. In a European genome-wide association study, four loci in a rare
         <em>
          IFIH1
         </em>
         variant were found in patients with sIgAD and may lead to the conclusions that sIgAD may be due to a complex network of gene effects. These loci also overlapped with autoimmune markers [
         <a href="#rid41">
          41
         </a>
         ]. These findings draw a loose connection between sIgAD and an autoimmune diathesis, although further studies are necessary to show causality.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H996035">
         <span class="h1">
          EPIDEMIOLOGY OF IgA DEFICIENCY
         </span>
         <span class="headingEndMark">
          —
         </span>
         sIgAD is the most common immunologic defect in humans [
         <a href="#rid42">
          42
         </a>
         ]. It is considered to be a primary humoral immunodeficiency, even though most affected individuals are asymptomatic. Estimates of prevalence are typically obtained through studies of healthy blood donors. Prevalence ranges from 1 in 100 to 1 in 1000 in White, Black, and Middle Eastern populations [
         <a href="#rid43">
          43-54
         </a>
         ]. The condition is less common in Asian populations, with prevalence rates ranging from 1 in 1615 to 1 in 19,000 in different regions of China and Japan [
         <a href="#rid55">
          55-57
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H996280">
         <span class="h2">
          Risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most significant risk factor for having IgA deficiency is a family history of either IgA deficiency or the more profound defect in antibody function, common variable immunodeficiency (CVID). First-degree relatives of affected individuals are 50 times more likely to be affected themselves compared with unaffected people. Affected mothers are more likely than affected fathers to transmit the disorder to their offspring [
         <a href="#rid58">
          58,59
         </a>
         ]. In the Swedish population, a higher frequency of IgA deficiency was found more commonly in monozygotic twins (1 in 241) and dizygotic twins (1 in 198), as compared with the normal population (1 in 600) [
         <a href="#rid60">
          60
         </a>
         ]. However, the exact pattern of inheritance of IgA deficiency remains unclear [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          CLINICAL MANIFESTATIONS IN SYMPTOMATIC PATIENTS
         </span>
        </p>
        <p class="headingAnchor" id="H997998">
         <span class="h2">
          Overview
         </span>
         <span class="headingEndMark">
          —
         </span>
         The majority of individuals with sIgAD are asymptomatic. Less than one-third come to medical attention and usually present with one or more of the following disorders [
         <a href="#rid61">
          61-63
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Recurrent sinopulmonary infections
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Autoimmune disorders
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Giardia lamblia
         </em>
         infections and other intestinal disorders
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Allergic disorders
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anaphylactic transfusion reactions
        </p>
        <p>
        </p>
        <p>
         Serum levels of IgA in deficient patients do not necessarily correlate with the occurrence or severity of these disorders, and the pathophysiologic relationship between the deficiency of IgA and the disorders listed above has not been clearly delineated. (See
         <a class="local">
          'Pathophysiology of IgA deficiency'
         </a>
         above.)
        </p>
        <p>
         As with other immune disorders, lymphomas and gastrointestinal malignancies have been reported, but it has not been established that patients with sIgAD are at increased risk for neoplastic disease [
         <a href="#rid64">
          64
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Recurrent infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some patients with sIgAD suffer from recurrent infections, most often affecting the sinopulmonary tract. Gastrointestinal infections are seen to a lesser degree. Sinopulmonary infections may be more common than gastrointestinal infections in sIgAD because secreted IgM, which may partially compensate for the deficiency of IgA, is more prominent in the gut than the respiratory tract [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h3">
          Sinopulmonary
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with sIgAD may experience recurrent otitis media, sinusitis, and/or pneumonia. Adults with sIgAD may also suffer from recurrent sinusitis and pulmonary infections, although otitis media is less common [
         <a href="#rid66">
          66,67
         </a>
         ]. These infections are most commonly caused by encapsulated bacteria (eg,
         <em>
          Streptococcus pneumoniae
         </em>
         ,
         <em>
          Haemophilus influenzae
         </em>
         ). There have been several reports of patients presenting with end-organ damage, such as bronchiectasis, due to chronic and recurrent infections [
         <a href="#rid68">
          68,69
         </a>
         ]. There is evidence to suggest that local airway acquired secretory sIgAD of patients with chronic obstructive pulmonary disease may allow chronic bacterial colonization, leading to inflammation and progressive destructive remodeling [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
         Common viral respiratory tract infections (colds), laryngitis, and infectious conjunctivitis were also more common in a case-control study of 32 adults with sIgAD compared with age- and sex-matched controls [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p>
         It can be difficult to know what constitutes an excessive number of sinopulmonary infections, although immunologic societies have estimated that four or more sinus or ear infections or two or more episodes of pneumonia within a single year is concerning for the presence of an inborn error of immunity (IEI) [
         <a href="#rid71">
          71,72
         </a>
         ]. However, not all patients with this number of infections will be found to have an immune defect. An individual's susceptibility to these common infections can vary tremendously from year to year, depending on multiple factors, such as exposure to children (for adults), variations in the incidence and virulence of common respiratory viruses, stress levels, and other transient fluctuations in health status. (See
         <a class="medical medical_review" href="/z/d/html/5949.html" rel="external">
          "Approach to the child with recurrent infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3908.html" rel="external">
          "Approach to the adult with recurrent infections"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h3">
          Gastrointestinal
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some IgA-deficient patients suffer from gastrointestinal infections due to
         <em>
          Giardia lamblia
         </em>
         [
         <a href="#rid73">
          73-76
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5723.html" rel="external">
          "Giardiasis: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
         Individuals with IgA deficiency appear to have adequate defenses against other types of gastrointestinal infections. As an example, patients were shown to clear rotavirus infections normally and generate higher levels of total IgG and IgG1 subclass antibodies compared with normal controls [
         <a href="#rid77">
          77
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Gastrointestinal disorders (noninfectious)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Celiac disease and inflammatory bowel disease occur with increased prevalence in patients with sIgAD [
         <a href="#rid38">
          38,78
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4774.html" rel="external">
          "Epidemiology, pathogenesis, and clinical manifestations of celiac disease in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/99315.html" rel="external">
          "Gastrointestinal manifestations in primary immunodeficiency"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h3">
          Celiac disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Screening programs have detected celiac disease in up to 8 percent of patients with sIgAD [
         <a href="#rid38">
          38,79
         </a>
         ], and 1 to 2 percent of all patients with celiac disease have sIgAD [
         <a href="#rid80">
          80
         </a>
         ]. Patients with celiac disease may present with classic symptoms related to malabsorption, including diarrhea, steatorrhea, weight loss, and nutrient or vitamin deficiencies. However, many patients with celiac disease exhibit only minor gastrointestinal complaints, have nongastrointestinal manifestations, or are asymptomatic. Testing strategies are discussed below. (See
         <a class="local">
          'Patients with symptoms of autoimmune/allergic diseases'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h3">
          Inflammatory bowel disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Inflammatory bowel diseases, including ulcerative colitis and Crohn disease, are associated with sIgAD, although the pathophysiologic relationship is unclear [
         <a href="#rid81">
          81-84
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In children and adolescents, inflammatory bowel diseases should be considered in those presenting with loose stools or bloody diarrhea, abdominal pain, weight loss or growth failure, perianal disease, anemia, arthritis, or delayed onset of puberty. (See
         <a class="medical medical_review" href="/z/d/html/5879.html" rel="external">
          "Clinical presentation and diagnosis of inflammatory bowel disease in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adults with ulcerative colitis usually present with diarrhea that is associated with blood. Accompanying symptoms include colicky abdominal pain, urgency, and tenesmus. Patients may also have fever, fatigue, and weight loss. Ulcerative colitis primarily involves the intestine but may be associated with several extraintestinal manifestations. (See
         <a class="medical medical_review" href="/z/d/html/4067.html" rel="external">
          "Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adults with Crohn disease usually present with persistent diarrhea accompanied by abdominal pain with or without gross bleeding, fatigue, and weight loss. Symptoms may be present for years before the diagnosis is made. (See
         <a class="medical medical_review" href="/z/d/html/4070.html" rel="external">
          "Clinical manifestations, diagnosis, and prognosis of Crohn disease in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h3">
          Nodular lymphoid hyperplasia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nodular lymphoid hyperplasia, also known as follicular lymphoid hyperplasia, is a benign finding in the small intestine that is associated with sIgAD, common variable immunodeficiency (CVID), and gastrointestinal lymphoma  (
         <a class="graphic graphic_picture graphicRef80570" href="/z/d/graphic/80570.html" rel="external">
          picture 1
         </a>
         ) [
         <a href="#rid85">
          85-88
         </a>
         ]. It is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4743.html" rel="external">
          "Clinical presentation and diagnosis of primary gastrointestinal lymphomas", section on 'Predisposing conditions'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h2">
          Anaphylactic reactions to blood products
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaphylactic reactions to blood products have been reported in patients with sIgAD, as well as in those with CVID [
         <a href="#rid89">
          89-99
         </a>
         ]. These reactions have been theorized to be due to the presence of antibodies directed against IgA, which can form in some patients with undetectable levels of serum IgA. Reactions occur when anti-IgA antibodies react to small amounts of IgA in plasma or immunoglobulin products. Plasma- or IgA-containing blood products include whole blood, red blood cells, platelets, fresh frozen plasma, cryoprecipitate, granulocytes, or intravenous
         <a class="drug drug_general" data-topicid="16471" href="/z/d/drug information/16471.html" rel="external">
          immune globulin
         </a>
         (IVIG) preparations containing IgA. However, only a minority of IgA-deficient patients forms anti-IgA antibodies, and there are several other reasons for anaphylactic reactions to blood products, which are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/7947.html" rel="external">
          "Immunologic transfusion reactions", section on 'Anaphylactic transfusion reactions'
         </a>
         .)
        </p>
        <p>
         Antibodies to IgA are generally only formed in patients whose serum IgA levels are below the limit of detection. The evaluation of such individuals and the evaluation of a patient with sIgAD who has experienced an anaphylactic reaction to a blood product are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3936.html" rel="external">
          "Selective IgA deficiency: Management and prognosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11805768">
         <span class="h2">
          Allergic diseases and asthma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Food allergies and respiratory allergies (ie, allergic rhinitis and allergic asthma) are prominent in patients with sIgAD, although the true prevalence is not well studied [
         <a href="#rid66">
          66,100
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13908820">
         <span class="h2">
          Autoimmune disorders and autoantibodies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Among patients followed in immunology clinics, approximately 20 to 30 percent of patients with sIgAD develop autoimmune disorders [
         <a href="#rid38">
          38,66,101,102
         </a>
         ]. In particular, systemic lupus erythematosus (SLE), Graves' disease, type 1 diabetes, vitiligo, both juvenile- and adult-onset rheumatoid arthritis, immune thrombocytopenia, and myasthenia gravis are associated with sIgAD, although there are some conflicting evidence for the association with myasthenia gravis [
         <a href="#rid38">
          38,103-115
         </a>
         ].
        </p>
        <p>
         Individuals with sIgAD have an increased prevalence of autoantibodies without symptoms of overt autoimmune disease [
         <a href="#rid101">
          101,116-120
         </a>
         ]. In one series comparing 60 sIgAD patients with a normal control population, 90 percent had detectable autoantibodies, and 40 percent had six or more autoantibodies [
         <a href="#rid116">
          116
         </a>
         ].
        </p>
        <p>
         False-positive pregnancy tests have been reported in IgA-deficient females, a phenomenon that has been attributed to the presence of heterophile antibodies [
         <a href="#rid121">
          121
         </a>
         ]. Heterophile antibodies are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/8318.html" rel="external">
          "Infectious mononucleosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13907922">
         <span class="h3">
          Theories concerning autoimmunity
         </span>
         <span class="headingEndMark">
          —
         </span>
         At first glance, it appears paradoxical that an autoimmune disorder could develop in the individual with a humoral immunodeficiency disease since this would require the emergence of self-reactive antibodies in a host with defective antibody production. Theories about the relationship between autoimmunity and IgA deficiency include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Autoimmunity is seen in several types of humoral immunodeficiencies, including sIgAD and CVID. The immune system is normally prevented from damaging self-tissues by the elimination (or negative selection) of cells that strongly react against self-antigens. These mechanisms are believed to be compromised in some humoral immunodeficiencies. (See
         <a class="medical medical_review" href="/z/d/html/13933.html" rel="external">
          "Normal B and T lymphocyte development"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3914.html" rel="external">
          "Primary humoral immunodeficiencies: An overview"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An alternative theory is that individuals with IgA deficiency have underlying genetic factors that independently predispose to autoimmunity, without there being a direct causal relationship between the IgA deficiency and autoimmune disease. The observation that the prevalence of autoimmune disorders is increased among first-degree relatives of patients with IgA deficiency supports this theory [
         <a href="#rid38">
          38,122
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A third theory posits that the compromised mucosal barrier in sIgAD allows for abnormal passage of food antigens through the gut wall. In some patients, this may lead to the formation of autoreactive antibodies and autoimmune disease due to molecular mimicry between large food proteins, such as milk, and host antigens. One study showed the presence of antibodies against milk in patients with IgA deficiency correlated with an increased frequency of serum autoantibodies [
         <a href="#rid123">
          123
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H13908416">
         <span class="h1">
          ASSOCIATED DISORDERS
         </span>
        </p>
        <p class="headingAnchor" id="H1099303225">
         <span class="h2">
          Other inborn errors of immunity
         </span>
         <span class="headingEndMark">
          —
         </span>
         IgA deficiency is associated with several inborn errors of immunity (IEI; previously "primary immunodeficiencies") [
         <a href="#rid124">
          124
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Humoral deficiencies
         </strong>
         – Some cases of sIgAD may progress to common variable immunodeficiency (CVID) [
         <a href="#rid125">
          125-130
         </a>
         ]. In addition, families have been described in which affected individuals progress from a normal immunologic state to IgA deficiency with and without IgG subclass deficiency or CVID [
         <a href="#rid23">
          23,24,131
         </a>
         ]. The propensity to progress to CVID may be stronger in familial and major histocompatibility complex (MHC) associated sIgAD or in patients with 18q deletion syndrome [
         <a href="#rid128">
          128,132
         </a>
         ]. In these cases, genetic testing may assist in defining specific humoral deficiencies. (See
         <a class="medical medical_review" href="/z/d/html/3904.html" rel="external">
          "Pathogenesis of common variable immunodeficiency", section on 'Genetics'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          IgG2 subclass deficiency
         </strong>
         – Deficiency in IgG2 has been described both as an isolated finding and in combination with IgG4 and/or IgA deficiency. (See
         <a class="medical medical_review" href="/z/d/html/3906.html" rel="external">
          "IgG subclass deficiency", section on 'IgG2 deficiency'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ataxia-telangiectasia
         </strong>
         – This is a disorder that presents in early childhood with
         <strong>
         </strong>
         progressive cerebellar ataxia, abnormal eye movements, other neurologic abnormalities, oculocutaneous telangiectasias, and immunodeficiency. (See
         <a class="medical medical_review" href="/z/d/html/6233.html" rel="external">
          "Ataxia-telangiectasia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          DiGeorge syndrome
         </strong>
         – This presents with conotruncal cardiac anomalies, hypoplastic thymus, and hypocalcemia, often in the setting of developmental delay and frequent infections. (See
         <a class="medical medical_review" href="/z/d/html/83396.html" rel="external">
          "DiGeorge (22q11.2 deletion) syndrome: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Recombination-activating gene (RAG) 1 and 2 deficiency
         </strong>
         – This is a form of severe combined immunodeficiency (SCID) involving a defect in lymphocyte gene rearrangement [
         <a href="#rid133">
          133
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3950.html" rel="external">
          "T-B-NK+ SCID: Pathogenesis, clinical manifestations, and diagnosis", section on 'RAG complex (initiation of recombination)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H83425541">
         <span class="h2">
          Risk for cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         Individuals with IgA deficiency have been found to have a moderately increased risk of developing cancer, particularly involving the gastrointestinal tract. This relationship has only been found in adults [
         <a href="#rid134">
          134
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h1">
          EVALUATION AND DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h2">
          Indications for evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         An evaluation for sIgAD is appropriate in the following patients:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A child with recurrent otitis media, sinusitis, and/or pneumonia
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An adult with recurrent/chronic sinusitis or pulmonary infections
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A patient of any age with one or more of the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Absence or low level of IgA on routine immunoglobulin examination
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Celiac disease
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Gastrointestinal infection with
         <em>
          Giardia lamblia
         </em>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Unexplained and recurrent autoimmune phenomena
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A family history of IgA deficiency or common variable immunodeficiency (CVID)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A past anaphylactic reaction to blood products
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h2">
          Initial laboratory evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         The initial evaluation should include the measurement of serum concentrations of IgA, IgG, and IgM. A repeat level of IgA should be done to confirm the initial test to ensure accurate diagnosis. In sIgAD, only IgA is low. Serum levels of IgG and IgM levels must be normal. In contrast, patients with CVID have low levels of IgG plus low levels of IgA, IgM, or both.
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h2">
          Diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of sIgAD is based on the finding of an isolated deficiency of serum IgA in the presence of normal IgG and IgM levels in a patient older than four years of age in whom other causes of hypogammaglobulinemia have been excluded.
        </p>
        <p>
         The evaluation of any serum immunoglobulins in children is best undertaken after the age of six months since maternal immunoglobulins (particularly IgG) are present until this age, although maternal IgA does not cross the placental barrier to a significant degree under normal circumstances. For this reason, children with antibody defects do not generally present with recurrent infections until this age, when maternal antibodies have been cleared and the child's underlying deficiency is unmasked.
        </p>
        <p>
         In children younger than four years, the diagnosis should be considered preliminary, and the child should be monitored over time to see if IgA levels normalize. IgA levels may normalize as late as adolescence [
         <a href="#rid135">
          135
         </a>
         ]. Observations about the natural history of sIgAD are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/3936.html" rel="external">
          "Selective IgA deficiency: Management and prognosis", section on 'Prognosis'
         </a>
         .)
        </p>
        <p>
         Two severities of sIgAD have been distinguished, which correlate with the certainty of the diagnosis [
         <a href="#rid136">
          136
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Severe deficiency/definitive diagnosis
         </strong>
         – A patient greater than four years of age with a serum IgA concentration of less than 7 mg/dL (the lower limit of detection for most assays) and normal serum levels of IgG and IgM. Other causes of hypogammaglobulinemia must be excluded.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Partial deficiency/probable diagnosis
         </strong>
         – A patient greater than four years of age with a serum IgA concentration higher than 7 mg/dL but below the lower limit of normal (defined as two standard deviations below the age-adjusted mean value). Serum levels of IgG and IgM must be normal, and other causes of hypogammaglobulinemia must be excluded.
        </p>
        <p>
        </p>
        <p>
         Note that some experts do not distinguish severe and partial deficiencies and reserve the diagnosis of IgA deficiency for patients with levels below 7 mg/dL [
         <a href="#rid137">
          137,138
         </a>
         ].
        </p>
        <p>
         Functional testing of the patient's humoral immune response using vaccine challenge is not part of the diagnostic criteria for sIgAD. However, this evaluation is indicated in a patient with recurrent sinopulmonary infections, as discussed in the next section.
        </p>
        <p>
         IgA deficiency with recurrent sinopulmonary infections and poor antibody response, particularly to polysaccharide antigens, may suggest that the underlying diagnosis of specific antibody deficiency or CVID is more appropriate. The evaluation may then progress to B cell phenotyping or immune genetic evaluation to define other humoral deficiencies.
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h2">
          Further evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Further evaluation depends on the patient's clinical presentation. This may include a complete blood count (CBC) with differential, chemistry panel, screening tests for autoimmunity (antinuclear antibodies and thyroid autoantibodies), and screening tests for chronic infection or inflammation (erythrocyte sedimentation rate [ESR] and/or a C-reactive protein [CRP]). A total serum immunoglobulin E (IgE) is also appropriate as a screen for allergic disease.
        </p>
        <p>
         The measurement of IgA in specific bodily fluids is considered a research tool and is not recommended, since IgA levels in secretions are highly variable. Patients with measurable serum IgA levels have sufficient secretory IgA, and patients with low serum IgA levels (&lt;7 mg/dL) can be assumed to have little or no secretory IgA. There is also no need to measure IgA isotypes (IgA1 and IgA2).
        </p>
        <p class="headingAnchor" id="H29">
         <span class="h3">
          Patients with recurrent infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sinus imaging and chest radiography should be considered if there is a history of lower or upper respiratory infection. In addition to serum levels of IgA, IgG, and IgM, a CBC with differential and total hemolytic complement (THC or CH50) assay should be obtained to screen for other immunologic causes of recurrent infections. If the serum IgG level is normal, then IgG subclasses should be measured as IgG2 subclass deficiency may coexist with IgA deficiency (which is designated IgA deficiency with IgG subclass deficiency) [
         <a href="#rid139">
          139
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3903.html" rel="external">
          "Laboratory evaluation of the immune system"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3906.html" rel="external">
          "IgG subclass deficiency"
         </a>
         .)
        </p>
        <p>
         Patients with sIgAD may have normal or impaired responses to protein and polysaccharide antigens, although antibody function is not part of the diagnostic criteria. Still, assessment of vaccine responses is clinically useful because, if it is impaired, then the cause of the patient's recurrent infections has been identified and
         <a class="drug drug_general" data-topicid="16471" href="/z/d/drug information/16471.html" rel="external">
          immune globulin
         </a>
         replacement therapy is sometimes indicated. In addition, patients with impaired antibody function should be monitored for evolution to CVID. IgA-deficient patients with immune abnormalities are more likely to suffer from severe and progressive infections [
         <a href="#rid102">
          102
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3929.html" rel="external">
          "Assessing antibody function as part of an immunologic evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3936.html" rel="external">
          "Selective IgA deficiency: Management and prognosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H87123196">
         <span class="h3">
          Patients with symptoms of autoimmune/allergic diseases
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with sIgAD have a higher incidence of celiac disease, rheumatoid arthritis, Graves' disease, type 1 diabetes, myasthenia gravis, asthma, upper respiratory allergy, and food allergy [
         <a href="#rid38">
          38,66
         </a>
         ]. Suggestive clinical clues should be followed up by appropriate investigations. When screening for celiac disease in patients with sIgAD, IgG-antigliadin antibodies or an IgG test for tissue transglutaminase is preferable to IgA-based assays, as the latter may be falsely negative [
         <a href="#rid104">
          104
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4771.html" rel="external">
          "Diagnosis of celiac disease in adults", section on 'Negative serology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H31">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of sIgAD includes other inborn errors of immunity (IEI) and secondary IgA deficiency due to medications.
        </p>
        <p class="headingAnchor" id="H32">
         <span class="h2">
          Other inborn errors of immunity
         </span>
         <span class="headingEndMark">
          —
         </span>
         IgA deficiency may be detected in a patient with another, more severe immunodeficiency, as discussed previously (see
         <a class="local">
          'Associated disorders'
         </a>
         above). In particular, the disorders below should be excluded in infants and older patients, respectively:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Transient hypogammaglobulinemia of infancy (THI)
         </strong>
         – THI may be defined as a prolongation of the "physiologic" hypogammaglobulinemia of infancy, which is normally observed during the first three to six months of life. Vaccine responses are normal in children with THI. The diagnostic criteria for THI vary somewhat worldwide. Most definitions require that IgG be reduced, with or without reductions in other immunoglobulin classes, but some criteria accept an isolated low IgA level as sufficient for the diagnosis. Because of the changing nature of immunoglobulin levels in young children, THI is an appropriate diagnosis for children under four years of age with low immunoglobulin levels, whereas the diagnosis of sIgAD is best deferred until the child is older than four. (See
         <a class="medical medical_review" href="/z/d/html/5951.html" rel="external">
          "Transient hypogammaglobulinemia of infancy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evolving common variable immunodeficiency (CVID) and other humoral immunodeficiencies
         </strong>
         – Patients with sIgAD who developed CVID over time have been reported [
         <a href="#rid126">
          126
         </a>
         ]. Therefore, patients who continue to suffer from repeated infections and develop conditions associated with CVID, such as autoimmune hemolytic anemia or thrombocytopenia, should have IgG levels and vaccine responses assessed periodically. The diagnosis of CVID requires low IgG
         <strong>
          and
         </strong>
         low IgA or low IgM, in conjunction with impaired vaccine response. In these cases, B cell phenotyping or immune genetic testing may elucidate the humoral etiology that is responsible for the deficit. (See
         <a class="local">
          'Associated disorders'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/3928.html" rel="external">
          "Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H33">
         <span class="h2">
          Drug-induced immunoglobulin disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several medications can cause low levels of IgA, usually in combination with reductions in serum levels of other immunoglobulin classes. Most of these are reversible with discontinuation of the responsible medication, although
         <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">
          cyclosporine
         </a>
         A has been reported to cause permanent IgA deficiency even after the drug has been stopped [
         <a href="#rid140">
          140
         </a>
         ].
        </p>
        <p>
         Examples of drugs that may cause reversible reductions in serum IgA levels include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antiseizure medications [
         <a href="#rid141">
          141
         </a>
         ], including
         <a class="drug drug_general" data-topicid="9769" href="/z/d/drug information/9769.html" rel="external">
          phenytoin
         </a>
         [
         <a href="#rid142">
          142-145
         </a>
         ],
         <a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">
          valproic acid
         </a>
         [
         <a href="#rid108">
          108
         </a>
         ],
         <a class="drug drug_general" data-topicid="9545" href="/z/d/drug information/9545.html" rel="external">
          lamotrigine
         </a>
         [
         <a href="#rid146">
          146
         </a>
         ],
         <a class="drug drug_general" data-topicid="9198" href="/z/d/drug information/9198.html" rel="external">
          carbamazepine
         </a>
         [
         <a href="#rid147">
          147
         </a>
         ], and
         <a class="drug drug_general" data-topicid="9862" href="/z/d/drug information/9862.html" rel="external">
          zonisamide
         </a>
         [
         <a href="#rid148">
          148
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9747" href="/z/d/drug information/9747.html" rel="external">
          D-penicillamine
         </a>
         [
         <a href="#rid149">
          149-151
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Aurothioglucose [
         <a href="#rid152">
          152
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9196" href="/z/d/drug information/9196.html" rel="external">
          Captopril
         </a>
         [
         <a href="#rid153">
          153,154
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9963" href="/z/d/drug information/9963.html" rel="external">
          Sulfasalazine
         </a>
         [
         <a href="#rid155">
          155
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fenclofenac [
         <a href="#rid156">
          156
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gold [
         <a href="#rid157">
          157
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thyroxine [
         <a href="#rid158">
          158
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">
          Cyclosporine
         </a>
         [
         <a href="#rid140">
          140
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1926306885">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112831.html" rel="external">
          "Society guideline links: Inborn errors of immunity (previously called primary immunodeficiencies)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H34">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition and role of IgA
         </strong>
         – Selective immunoglobulin A (IgA) deficiency (sIgAD; MIM 137100) may be defined as the selective deficiency of serum IgA (ie, serum levels of immunoglobulin G [IgG] and immunoglobulin M [IgM] are normal) in a patient older than four years of age, in whom other causes of hypogammaglobulinemia have been excluded. IgA is concentrated in mucosal secretions and is believed to be important in the immune functioning of the mucosal barrier. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Normal biology of IgA'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          sIgAD is usually asymptomatic
         </strong>
         – The vast majority of individuals with sIgAD do not suffer from increased infections or other disorders, possibly because there are redundant immune mechanisms that can compensate in most IgA-deficient individuals. The pathophysiology is largely unknown and may result from several different mechanisms. (See
         <a class="local">
          'Pathophysiology of IgA deficiency'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          sIgAD is common
         </strong>
         – sIgAD is considered the most common immunodeficiency in humans, with prevalence ranges from 1 in 100 to 1 in 1000 in White, Black, and Middle Eastern populations. It is less common in Asian populations. (See
         <a class="local">
          'Epidemiology of IgA deficiency'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Disorders in symptomatic patients
         </strong>
         – A minority of individuals with sIgAD are symptomatic. These patients may develop recurrent sinopulmonary infections, autoimmune disorders, gastrointestinal disorders, allergic diseases, and rare anaphylactic reactions to blood products. (See
         <a class="local">
          'Clinical manifestations in symptomatic patients'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          sIgAD is a diagnosis of exclusion
         </strong>
         – Evaluation begins with measurement of serum levels of IgA, immunoglobulin G (IgG), and immunoglobulin M (IgM). Serum levels of IgG and IgM levels must be normal to consider the diagnosis of sIgAD. A low level of IgA must be confirmed with a repeat measurement. Two severities of sIgAD are distinguished. A serum IgA level &lt;7 mg/dL is considered severe deficiency. Partial deficiency refers to a level above 7 mg/dL but below the lower limit of age-adjusted normal. Further evaluation depends upon the patient's clinical presentation. (See
         <a class="local">
          'Evaluation and diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – Other disorders in which serum IgA may be low include several other immune disorders and secondary IgA deficiency due to medications. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H991295359">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges E Richard Stiehm, MD, who contributed as a Section Editor to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Yel L. Selective IgA deficiency. J Clin Immunol 2010; 30:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hostoffer RW, Krukovets I, Berger M. Increased Fc alpha R expression and IgA-mediated function on neutrophils induced by chemoattractants. J Immunol 1993; 150:4532.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monteiro RC, Hostoffer RW, Cooper MD, et al. Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest 1993; 92:1681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brandtzaeg P, Nilssen DE, Rognum TO, Thrane PS. Ontogeny of the mucosal immune system and IgA deficiency. Gastroenterol Clin North Am 1991; 20:397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mellander L, Björkander J, Carlsson B, Hanson LA. Secretory antibodies in IgA-deficient and immunosuppressed individuals. J Clin Immunol 1986; 6:284.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brandtzaeg P, Karlsson G, Hansson G, et al. The clinical condition of IgA-deficient patients is related to the proportion of IgD- and IgM-producing cells in their nasal mucosa. Clin Exp Immunol 1987; 67:626.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klemola T. Immunohistochemical findings in the intestine of IgA-deficient persons: number of intraepithelial T lymphocytes is increased. J Pediatr Gastroenterol Nutr 1988; 7:537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mestecky J, Zikan J, Butler WT. Immunoglobulin M and secretory immunoglobulin A: presence of a common polypeptide chain different from light chains. Science 1971; 171:1163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Savilahti E. IgA deficiency in children. Immunoglobulin-containing cells in the intestinal mucosa, immunoglobulins in secretions and serum IgA levels. Clin Exp Immunol 1973; 13:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Low TL, Liu YS, Putnam FW. Structure, function, and evolutionary relationships of Fc domains of human immunoglobulins A, G, M, and E. Science 1976; 191:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Borte S, Pan-Hammarström Q, Liu C, et al. Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency. Blood 2009; 114:4089.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Husain Z, Holodick N, Day C, et al. Increased apoptosis of CD20+ IgA + B cells is the basis for IgA deficiency: the molecular mechanism for correction in vitro by IL-10 and CD40L. J Clin Immunol 2006; 26:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramsay AJ, Husband AJ, Ramshaw IA, et al. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994; 264:561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Okahashi N, Yamamoto M, Vancott JL, et al. Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect Immun 1996; 64:1516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Snapper CM, Zelazowski P, Rosas FR, et al. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J Immunol 1996; 156:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brière F, Chevet D, Bridon JM, et al. [B lymphocytes of patients with complete IgA deficiency secrete IgA in response to interleukin 10]. Nephrologie 1996; 17:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kowalczyk D, Mytar B, Zembala M. Cytokine production in transient hypogammaglobulinemia and isolated IgA deficiency. J Allergy Clin Immunol 1997; 100:556.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nechvatalova J, Pikulova Z, Stikarovska D, et al. B-lymphocyte subpopulations in patients with selective IgA deficiency. J Clin Immunol 2012; 32:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soheili H, Abolhassani H, Arandi N, et al. Evaluation of natural regulatory T cells in subjects with selective IgA deficiency: from senior idea to novel opportunities. Int Arch Allergy Immunol 2013; 160:208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pan-Hammarström Q, Salzer U, Du L, et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007; 39:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Castigli E, Wilson SA, Garibyan L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005; 37:829.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rachid R, Castigli E, Geha RS, Bonilla FA. TACI mutation in common variable immunodeficiency and IgA deficiency. Curr Allergy Asthma Rep 2006; 6:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koistinen J. Familial clustering of selective IgA deficiency. Vox Sang 1976; 30:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vassallo CL, Zawadzki ZA, Simons JR. Recurrent respiratory infections in a family with immunoglobulin A deficiency. Am Rev Respir Dis 1970; 101:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewkonia RM, Gairdner D, Doe WF. IgA deficiency in one of identical twins. Br Med J 1976; 1:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gilgenkrantz S, Charles JM, Cabrol C, et al. [Deletion of the short arm of chromosome 18 due to t(22-;18p+) translocation with IgA deficiency. Cytogenetic study with autoradiography and fluorescence]. Ann Genet 1972; 15:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murken JD, Salzer G, Kunze D. [Ring-chromosome 18 and IgA deficiency in a 6-year-old girl (46,XX,18r)]. Z Kinderheilkd 1970; 109:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ogata K, Iinuma K, Kammura K, et al. A case report of a presumptive +i(18p) associated with serum IgA deficiency. Clin Genet 1977; 11:184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schäffer AA, Pfannstiel J, Webster AD, et al. Analysis of families with common variable immunodeficiency (CVID) and IgA deficiency suggests linkage of CVID to chromosome 16q. Hum Genet 2006; 118:725.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herrmann RP, Chipper L, Bell S. Chromosomal studies in healthy blood donors with IgA deficiency. Clin Genet 1982; 22:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vorechovský I, Cullen M, Carrington M, et al. Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families. J Immunol 2000; 164:4408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lakhanpal S, O'Duffy JD, Homburger HA, Moore SB. Evidence for linkage of IgA deficiency with the major histocompatibility complex. Mayo Clin Proc 1988; 63:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heikkilä M, Koistinen J, Lohman M, Koskimies S. Increased frequency of HLA-A1 and -B8 in association with total lack, but not with deficiency of serum IgA. Tissue Antigens 1984; 23:280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De La Concha EG, Fernandez-Arquero M, Martinez A, et al. HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID). Clin Exp Immunol 1999; 116:516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schroeder HW Jr, Zhu ZB, March RE, et al. Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes. Mol Med 1998; 4:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olerup O, Smith CI, Hammarström L. Different amino acids at position 57 of the HLA-DQ beta chain associated with susceptibility and resistance to IgA deficiency. Nature 1990; 347:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pozo ND, Medrano LM, Cénit MC, et al. MSH5 is not a genetic predisposing factor for immunoglobulin A deficiency but marks the HLA-DRB1*0102 subgroup carrying susceptibility. Hum Immunol 2010; 71:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang N, Shen N, Vyse TJ, et al. Selective IgA deficiency in autoimmune diseases. Mol Med 2011; 17:1383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohammadi J, Ramanujam R, Jarefors S, et al. IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype. J Clin Immunol 2010; 30:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferreira RC, Pan-Hammarström Q, Graham RR, et al. Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat Genet 2010; 42:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bronson PG, Chang D, Bhangale T, et al. Common variants at PVT1, ATG13-AMBRA1, AHI1 and CLEC16A are associated with selective IgA deficiency. Nat Genet 2016; 48:1425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stiehm ER. The four most common pediatric immunodeficiencies. J Immunotoxicol 2008; 5:227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           al-Attas RA, Rahi AH. Primary antibody deficiency in Arabs: first report from eastern Saudi Arabia. J Clin Immunol 1998; 18:368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pereira LF, Sapiña AM, Arroyo J, et al. Prevalence of selective IgA deficiency in Spain: more than we thought. Blood 1997; 90:893.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ezeoke AC. Selective IgA deficiency (SIgAD) in Eastern Nigeria. Afr J Med Med Sci 1988; 17:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Litzman J, Sevcíková I, Stikarovská D, et al. IgA deficiency in Czech healthy individuals and selected patient groups. Int Arch Allergy Immunol 2000; 123:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gudmundsson S, Jensson O. Frequency of IgA deficiency in blood donors and Rh negative women in Iceland. Acta Pathol Microbiol Scand C 1977; 85:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saghafi S, Pourpak Z, Aghamohammadi A, et al. Selective immunoglobulin A deficiency in Iranian blood donors: prevalence, laboratory and clinical findings. Iran J Allergy Asthma Immunol 2008; 7:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holt PD, Tandy NP, Anstee DJ. Screening of blood donors for IgA deficiency: a study of the donor population of south-west England. J Clin Pathol 1977; 30:1007.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carneiro-Sampaio MM, Carbonare SB, Rozentraub RB, et al. Frequency of selective IgA deficiency among Brazilian blood donors and healthy pregnant women. Allergol Immunopathol (Madr) 1989; 17:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palmer DS, O'Toole J, Montreuil T, et al. Screening of Canadian Blood Services donors for severe immunoglobulin A deficiency. Transfusion 2010; 50:1524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giza S, Kotanidou E, Papadopoulou-Alataki E, et al. Prevalence of selective immunoglobulin A deficiency in Greek children and adolescents with type 1 diabetes. World J Pediatr 2016; 12:470.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lu P, Ling B, Wang N, Hammarstrom L. [Study on immunoglobulin A Deficiency(IgAD) in Chinese Shanghai Blood Donors]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2016; 24:1216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Urbonas V, Sadauskaite J, Cerkauskiene R, et al. Population-Based Screening for Selective Immunoglobulin A (IgA) Deficiency in Lithuanian Children Using a Rapid Antibody-Based Fingertip Test. Med Sci Monit 2016; 22:4773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feng ML, Zhao YL, Shen T, et al. Prevalence of immunoglobulin A deficiency in Chinese blood donors and evaluation of anaphylactic transfusion reaction risk. Transfus Med 2011; 21:338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feng L. [Epidemiological study of selective IgA deficiency among 6 nationalities in China]. Zhonghua Yi Xue Za Zhi 1992; 72:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanoh T, Mizumoto T, Yasuda N, et al. Selective IgA deficiency in Japanese blood donors: frequency and statistical analysis. Vox Sang 1986; 50:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vorechovský I, Webster AD, Plebani A, Hammarström L. Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition. Am J Hum Genet 1999; 64:1096.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vorechovský I, Zetterquist H, Paganelli R, et al. Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 1995; 77:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frankowiack M, Kovanen RM, Repasky GA, et al. The higher frequency of IgA deficiency among Swedish twins is not explained by HLA haplotypes. Genes Immun 2015; 16:199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aytekin C, Tuygun N, Gokce S, et al. Selective IgA deficiency: clinical and laboratory features of 118 children in Turkey. J Clin Immunol 2012; 32:961.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Domínguez O, Giner MT, Alsina L, et al. [Clinical phenotypes associated with selective IgA deficiency: a review of 330 cases and a proposed follow-up protocol]. An Pediatr (Barc) 2012; 76:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shkalim V, Monselize Y, Segal N, et al. Selective IgA deficiency in children in Israel. J Clin Immunol 2010; 30:761.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mellemkjaer L, Hammarstrom L, Andersen V, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol 2002; 130:495.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol 2008; 1:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jorgensen GH, Gardulf A, Sigurdsson MI, et al. Clinical symptoms in adults with selective IgA deficiency: a case-control study. J Clin Immunol 2013; 33:742.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ocampo CJ, Peters AT. Antibody deficiency in chronic rhinosinusitis: epidemiology and burden of illness. Am J Rhinol Allergy 2013; 27:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chipps BE, Talamo RC, Winkelstein JA. IgA deficiency, recurrent pneumonias, and bronchiectasis. Chest 1978; 73:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gomez-Carrasco JA, Barrera-Gómez MJ, García-Mouriño V, et al. Selective and partial IgA deficiency in an adolescent male with bronchiectasis. Allergol Immunopathol (Madr) 1994; 22:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polosukhin VV, Richmond BW, Du RH, et al. Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and Remodeling. Am J Respir Crit Care Med 2017; 195:1010.
          </a>
         </li>
         <li class="breakAll">
          The 6 warning signs for primary immunodeficiency in adults were developed by the European Society for Immunodeficiencies. Available on the web at http://www.esid.org/workingparty.php?party=3&amp;sub=2id=175.
         </li>
         <li class="breakAll">
          Ten warning signs for primary immunodeficiency in adults. http://www.info4pi.org/aboutPI/index.cfm?section=aboutPI&amp;content=warningsignsadult&amp;CFID=40450642&amp;CFTOKEN=62808651 (Accessed on November 06, 2012).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eren M, Saltik-Temizel IN, Yüce A, et al. Duodenal appearance of giardiasis in a child with selective immunoglobulin A deficiency. Pediatr Int 2007; 49:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carretero Gomez J, Vera Tomé A, Arévalo Lorido JC, Muñoz Sanz A. [Follicular lymphoid hyperplasia, IgA deficiency and coinfecction of Giardia lamblia and Epstein-Barr virus]. Gastroenterol Hepatol 2003; 26:397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gato Morais R, Báñez Sánchez F, Pascual García J, et al. [Reactive arthritis due to Giardia lamblia in a patient with IgA deficiency]. An Med Interna 1998; 15:398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Langford TD, Housley MP, Boes M, et al. Central importance of immunoglobulin A in host defense against Giardia spp. Infect Immun 2002; 70:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Istrate C, Hinkula J, Hammarström L, Svensson L. Individuals with selective IgA deficiency resolve rotavirus disease and develop higher antibody titers (IgG, IgG1) than IgA competent individuals. J Med Virol 2008; 80:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agarwal S, Mayer L. Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J Allergy Clin Immunol 2009; 124:658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meini A, Pillan NM, Villanacci V, et al. Prevalence and diagnosis of celiac disease in IgA-deficient children. Ann Allergy Asthma Immunol 1996; 77:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cataldo F, Marino V, Bottaro G, et al. Celiac disease and selective immunoglobulin A deficiency. J Pediatr 1997; 131:306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asada Y, Isomoto H, Shikuwa S, et al. Development of ulcerative colitis during the course of rheumatoid arthritis: Association with selective IgA deficiency. World J Gastroenterol 2006; 12:5240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manfredi R, Coronado OV, Marinacci G, et al. Chron's disease, rare association with selective IgA immunodeficiency, and development of life-threatening bacterial infections. Scand J Infect Dis 2004; 36:523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iizuka M, Itou H, Sato M, et al. Crohn's disease associated with selective immunoglobulin a deficiency. J Gastroenterol Hepatol 2001; 16:951.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Curzio M, Bernasconi G, Gullotta R, et al. Association of ulcerative colitis, sclerosing cholangitis and cholangiocarcinoma in a patient with IgA deficiency. Endoscopy 1985; 17:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joo M, Shim SH, Chang SH, et al. Nodular lymphoid hyperplasia and histologic changes mimicking celiac disease, collagenous sprue, and lymphocytic colitis in a patient with selective IgA deficiency. Pathol Res Pract 2009; 205:876.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pytrus T, Iwańczak B, Iwańczak F. [Nodular lymphoid hyperplasia--underestimated problem of gastrointestinal tract pathology in children]. Pol Merkur Lekarski 2008; 24:449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piaścik M, Rydzewska G, Pawlik M, et al. Diffuse nodular lymphoid hyperplasia of the gastrointestinal tract in patient with selective immunoglobulin A deficiency and sarcoid-like syndrome--case report. Adv Med Sci 2007; 52:296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Atarod L, Raissi A, Aghamohammadi A, et al. A review of gastrointestinal disorders in patients with primary antibody immunodeficiencies during a 10-year period (1990-2000), in children hospital medical center. Iran J Allergy Asthma Immunol 2003; 2:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horn J, Thon V, Bartonkova D, et al. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy. Clin Immunol 2007; 122:156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pineda AA, Taswell HF. Transfusion reactions associated with anti-IgA antibodies: report of four cases and review of the literature. Transfusion 1975; 15:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buckley RH, Schiff RI. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 1991; 325:110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferreira A, Garcia Rodriguez MC, Lopez-Trascasa M, et al. Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with gamma-globulin. Clin Immunol Immunopathol 1988; 47:199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sandler SG, Mallory D, Malamut D, Eckrich R. IgA anaphylactic transfusion reactions. Transfus Med Rev 1995; 9:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vassallo RR. Review: IgA anaphylactic transfusion reactions. Part I. Laboratory diagnosis, incidence, and supply of IgA-deficient products. Immunohematology 2004; 20:226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hammarström L, Persson MA, Smith CI. Anti-IgA in selective IgA deficiency. In vitro effects and Ig subclass pattern of human anti-IgA. Scand J Immunol 1983; 18:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Björkander J, Hammarström L, Smith CI, et al. Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies. J Clin Immunol 1987; 7:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Albuquerque Campos R, Sato MN, da Silva Duarte AJ. IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy. J Clin Immunol 2000; 20:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lilic D, Sewell WA. IgA deficiency: what we should-or should not-be doing. J Clin Pathol 2001; 54:337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chowdary P, Nair D, Davies N, et al. Anaphylactic reaction with prothrombin complex concentrate in a patient with IgA deficiency and anti-IgA antibodies. Blood Coagul Fibrinolysis 2010; 21:764.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Janzi M, Kull I, Sjöberg R, et al. Selective IgA deficiency in early life: association to infections and allergic diseases during childhood. Clin Immunol 2009; 133:78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin Immunol 2004; 111:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aghamohammadi A, Cheraghi T, Gharagozlou M, et al. IgA deficiency: correlation between clinical and immunological phenotypes. J Clin Immunol 2009; 29:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rankin EC, Isenberg DA. IgA deficiency and SLE: prevalence in a clinic population and a review of the literature. Lupus 1997; 6:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGowan KE, Lyon ME, Butzner JD. Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic. Clin Chem 2008; 54:1203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yewdall V, Cameron JS, Nathan AW, et al. Systemic lupus erythematosus and IgA deficiency. J Clin Lab Immunol 1983; 10:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maeda M, Kitamura Y, Takata M, et al. [A case of systemic lupus erythematosus demonstrating basal ganglia calcifications, coronary stenosis and selective IgA deficiency]. Nihon Naika Gakkai Zasshi 1986; 75:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanoh T, Nishimura T, Tokunaga Y. [A case of 21-year-old man with selective IgA deficiency, complicated with systemic lupus erythematosus and papillary adenocarcinoma of thyroid gland]. Nihon Naika Gakkai Zasshi 1987; 76:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joubert PH, Aucamp AK, Potgieter GM, Verster F. Epilepsy and IgA deficiency--the effect of sodium valproate. S Afr Med J 1977; 52:642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pelkonen P, Savilahti E, Mäkelä AL. Persistent and transient IgA deficiency in juvenile rheumatoid arthritis. Scand J Rheumatol 1983; 12:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Badcock LJ, Clarke S, Jones PW, et al. Abnormal IgA levels in patients with rheumatoid arthritis. Ann Rheum Dis 2003; 62:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurien M, Leeds JS, Hopper AD, et al. Serological testing for coeliac disease in Type 1 diabetes mellitus: is immunoglobulin A level measurement necessary? Diabet Med 2013; 30:840.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramanujam R, Piehl F, Pirskanen R, et al. Concomitant autoimmunity in myasthenia gravis--lack of association with IgA deficiency. J Neuroimmunol 2011; 236:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mantovani AP, Monclaro MP, Skare TL. Prevalence of IgA deficiency in adult systemic lupus erythematosus and the study of the association with its clinical and autoantibody profiles. Rev Bras Reumatol 2010; 50:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beltrán Agulló V, Saumoy Linares M, Escoda Teigell L, Ugarriza Sagaste A. [Refractory idiopathic thrombocytopenic purpura and selective IgA deficiency]. Rev Clin Esp 2002; 202:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abolhassani H, Gharib B, Shahinpour S, et al. Autoimmunity in patients with selective IgA deficiency. J Investig Allergol Clin Immunol 2015; 25:112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barka N, Shen GQ, Shoenfeld Y, et al. Multireactive pattern of serum autoantibodies in asymptomatic individuals with immunoglobulin A deficiency. Clin Diagn Lab Immunol 1995; 2:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ammann AJ, Hong R. Selective IgA deficiency and autoimmunity. Clin Exp Immunol 1970; 7:833.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ablin RJ. Anti-tissue IgG antibodies and deficiency of IgA. Vox Sang 1972; 23:371.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wells JV, Michaeli D, Fudenberg HH. Antibodies to human collagen in subjects with selective IgA deficiency. Clin Exp Immunol 1973; 13:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gulez N, Karaca NE, Aksu G, Kutukculer N. Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations. Autoimmunity 2009; 42:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knight AK, Bingemann T, Cole L, Cunningham-Rundles C. Frequent false positive beta human chorionic gonadotropin tests in immunoglobulin A deficiency. Clin Exp Immunol 2005; 141:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jorgensen GH, Thorsteinsdottir I, Gudmundsson S, et al. Familial aggregation of IgAD and autoimmunity. Clin Immunol 2009; 131:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cunningham-Rundles C, Brandeis WE, Pudifin DJ, et al. Autoimmunity in selective IgA deficiency: relationship to anti-bovine protein antibodies, circulating immune complexes and clinical disease. Clin Exp Immunol 1981; 45:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bousfiha A, Jeddane L, Picard C, et al. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. J Clin Immunol 2020; 40:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Español T, Catala M, Hernandez M, et al. Development of a common variable immunodeficiency in IgA-deficient patients. Clin Immunol Immunopathol 1996; 80:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aghamohammadi A, Mohammadi J, Parvaneh N, et al. Progression of selective IgA deficiency to common variable immunodeficiency. Int Arch Allergy Immunol 2008; 147:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gutierrez MG, Kirkpatrick CH. Progressive immunodeficiency in a patient with IgA deficiency. Ann Allergy Asthma Immunol 1997; 79:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slyper AH, Pietryga D. Conversion of selective IgA deficiency to common variable immunodeficiency in an adolescent female with 18q deletion syndrome. Eur J Pediatr 1997; 156:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Litzman J, Burianova M, Thon V, Lokaj J. Progression of selective IgA deficiency to common variable immunodeficiency in a 16 year old boy. Allergol Immunopathol (Madr) 1996; 24:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hostoffer RW, Bay CA, Wagner K, et al. Kabuki make-up syndrome associated with an acquired hypogammaglobulinemia and anti-IgA antibodies. Clin Pediatr (Phila) 1996; 35:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson ML, Keeton LG, Zhu ZB, et al. Age-related changes in serum immunoglobulins in patients with familial IgA deficiency and common variable immunodeficiency (CVID). Clin Exp Immunol 1997; 108:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson MG, Towner JW, Forsman I, Siris E. Syndromes associated with deletion of the long arm of chromosome 18[del(18q)]. Am J Med Genet 1979; 3:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kato T, Crestani E, Kamae C, et al. RAG1 deficiency may present clinically as selective IgA deficiency. J Clin Immunol 2015; 35:280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ludvigsson JF, Neovius M, Ye W, Hammarström L. IgA deficiency and risk of cancer: a population-based matched cohort study. J Clin Immunol 2015; 35:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lim CK, Dahle C, Elvin K, et al. Reversal of Immunoglobulin A Deficiency in Children. J Clin Immunol 2015; 35:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999; 93:190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonilla FA, Khan DA, Ballas ZK, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol 2015; 136:1186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tangye SG, Al-Herz W, Bousfiha A, et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 2022; 42:1473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chapel H. Classification of primary immunodeficiency diseases by the International Union of Immunological Societies (IUIS) Expert Committee on Primary Immunodeficiency 2011. Clin Exp Immunol 2012; 168:58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murphy EA, Morris AJ, Walker E, et al. Cyclosporine A induced colitis and acquired selective IgA deficiency in a patient with juvenile chronic arthritis. J Rheumatol 1993; 20:1397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashrafi M, Hosseini SA, Abolmaali S, et al. Effect of anti-epileptic drugs on serum immunoglobulin levels in children. Acta Neurol Belg 2010; 110:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gilhus NE, Aarli JA. The reversibility of phenytoin-induced IgA deficiency. J Neurol 1981; 226:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruff ME, Pincus LG, Sampson HA. Phenytoin-induced IgA depression. Am J Dis Child 1987; 141:858.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Talesnik E, Rivero SJ, González B. Serum IgA deficiency induced by prolonged phenytoin treatment. Rev Invest Clin 1989; 41:331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braconier JH. Reversible total IgA deficiency associated with phenytoin treatment. Scand J Infect Dis 1999; 31:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maruyama S, Okamoto Y, Toyoshima M, et al. Immunoglobulin A deficiency following treatment with lamotrigine. Brain Dev 2016; 38:947.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kato Z, Watanabe M, Kondo N. IgG2, IgG4 and IgA deficiency possibly associated with carbamazepine treatment. Eur J Pediatr 2003; 162:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maeoka Y, Hara T, Dejima S, Takeshita K. IgA and IgG2 deficiency associated with zonisamide therapy: a case report. Epilepsia 1997; 38:611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ibel H, Feist D, Endres W, Belohradsky BH. [D-penicillamine-induced IgA deficiency in the therapy of Wilson's disease]. Klin Padiatr 1990; 202:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Götze H. [D-penicillamin-induced IgA-deficiency (author's transl)]. Klin Padiatr 1979; 191:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forrest RD, Boström H, Dahlberg PA. IgA deficiency during penicillamine treatment. Br Med J 1977; 1:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Riel PL, van de Putte LB, Gribnau FW, de Waal RM. IgA deficiency during aurothioglucose treatment. A case report. Scand J Rheumatol 1984; 13:334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suzuki T, Okada J, Kashiwazaki S. Selective IgA deficiency developed during treatment of scleroderma kidney with captopril. J Rheumatol 1988; 15:716.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hammarström L, Smith CI, Berg CI. Captopril-induced IgA deficiency. Lancet 1991; 337:436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farr M, Kitas GD, Tunn EJ, Bacon PA. Immunodeficiencies associated with sulphasalazine therapy in inflammatory arthritis. Br J Rheumatol 1991; 30:413.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farr M, Struthers GR, Scott DG, Bacon PA. Fenclofenac-induced selective IgA deficiency in rheumatoid arthritis. Br J Rheumatol 1985; 24:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stanworth DR, Williamson JP, Shadforth M, et al. Drug-induced IgA deficiency in rheumatoid arthritis. Lancet 1977; 1:1001.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seager J. IgA deficiency during treatment of infantile hypothyroidism with thyroxine. Br Med J (Clin Res Ed) 1984; 288:1562.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3963 Version 33.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20101521" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Selective IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8387096" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Increased Fc alpha R expression and IgA-mediated function on neutrophils induced by chemoattractants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8408621" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1917020" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Ontogeny of the mucosal immune system and IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3489000" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Secretory antibodies in IgA-deficient and immunosuppressed individuals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3301101" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The clinical condition of IgA-deficient patients is related to the proportion of IgD- and IgM-producing cells in their nasal mucosa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3294370" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Immunohistochemical findings in the intestine of IgA-deficient persons: number of intraepithelial T lymphocytes is increased.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5544873" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Immunoglobulin M and secretory immunoglobulin A: presence of a common polypeptide chain different from light chains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4633850" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : IgA deficiency in children. Immunoglobulin-containing cells in the intestinal mucosa, immunoglobulins in secretions and serum IgA levels.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1246619" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Structure, function, and evolutionary relationships of Fc domains of human immunoglobulins A, G, M, and E.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19738033" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16758339" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Increased apoptosis of CD20+ IgA + B cells is the basis for IgA deficiency: the molecular mechanism for correction in vitro by IL-10 and CD40L.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8160012" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The role of interleukin-6 in mucosal IgA antibody responses in vivo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8613355" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8598461" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8927208" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : [B lymphocytes of patients with complete IgA deficiency secrete IgA in response to interleukin 10].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9338552" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Cytokine production in transient hypogammaglobulinemia and isolated IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22328142" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : B-lymphocyte subpopulations in patients with selective IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23018812" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Evaluation of natural regulatory T cells in subjects with selective IgA deficiency: from senior idea to novel opportunities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17392797" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16007086" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : TACI is mutant in common variable immunodeficiency and IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16899196" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : TACI mutation in common variable immunodeficiency and IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1251582" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Familial clustering of selective IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4188959" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Recurrent respiratory infections in a family with immunoglobulin A deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/942876" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : IgA deficiency in one of identical twins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4539488" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : [Deletion of the short arm of chromosome 18 due to t(22-;18p+) translocation with IgA deficiency. Cytogenetic study with autoradiography and fluorescence].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5478808" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : [Ring-chromosome 18 and IgA deficiency in a 6-year-old girl (46,XX,18r)].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/837568" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : A case report of a presumptive +i(18p) associated with serum IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16328471" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Analysis of families with common variable immunodeficiency (CVID) and IgA deficiency suggests linkage of CVID to chromosome 16q.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7151309" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Chromosomal studies in healthy blood donors with IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10754342" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3361955" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Evidence for linkage of IgA deficiency with the major histocompatibility complex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6611606" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Increased frequency of HLA-A1 and -B8 in association with total lack, but not with deficiency of serum IgA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10361244" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9508785" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1976229" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Different amino acids at position 57 of the HLA-DQ beta chain associated with susceptibility and resistance to IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20542071" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : MSH5 is not a genetic predisposing factor for immunoglobulin A deficiency but marks the HLA-DRB1*0102 subgroup carrying susceptibility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21826374" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Selective IgA deficiency in autoimmune diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19834793" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20694011" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27723758" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Common variants at PVT1, ATG13-AMBRA1, AHI1 and CLEC16A are associated with selective IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18569394" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : The four most common pediatric immunodeficiencies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9793829" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Primary antibody deficiency in Arabs: first report from eastern Saudi Arabia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9226194" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Prevalence of selective IgA deficiency in Spain: more than we thought.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2834928" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Selective IgA deficiency (SIgAD) in Eastern Nigeria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11060491" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : IgA deficiency in Czech healthy individuals and selected patient groups.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/404845" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Frequency of IgA deficiency in blood donors and Rh negative women in Iceland.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18780950" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Selective immunoglobulin A deficiency in Iranian blood donors: prevalence, laboratory and clinical findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/304071" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Screening of blood donors for IgA deficiency: a study of the donor population of south-west England.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2816663" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Frequency of selective IgA deficiency among Brazilian blood donors and healthy pregnant women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20158683" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Screening of Canadian Blood Services donors for severe immunoglobulin A deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27286692" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Prevalence of selective immunoglobulin A deficiency in Greek children and adolescents with type 1 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27531803" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : [Study on immunoglobulin A Deficiency(IgAD) in Chinese Shanghai Blood Donors].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27920422" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Population-Based Screening for Selective Immunoglobulin A (IgA) Deficiency in Lithuanian Children Using a Rapid Antibody-Based Fingertip Test.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21658139" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Prevalence of immunoglobulin A deficiency in Chinese blood donors and evaluation of anaphylactic transfusion reaction risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1327440" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : [Epidemiological study of selective IgA deficiency among 6 nationalities in China].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3485858" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Selective IgA deficiency in Japanese blood donors: frequency and statistical analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10090895" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7586726" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Family and linkage study of selective IgA deficiency and common variable immunodeficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25569265" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : The higher frequency of IgA deficiency among Swedish twins is not explained by HLA haplotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22547079" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Selective IgA deficiency: clinical and laboratory features of 118 children in Turkey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22240193" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : [Clinical phenotypes associated with selective IgA deficiency: a review of 330 cases and a proposed follow-up protocol].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20571893" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Selective IgA deficiency in children in Israel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12452841" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19079156" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : The immune geography of IgA induction and function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23389234" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Clinical symptoms in adults with selective IgA deficiency: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23406598" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Antibody deficiency in chronic rhinosinusitis: epidemiology and burden of illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/305332" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : IgA deficiency, recurrent pneumonias, and bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7892814" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Selective and partial IgA deficiency in an adolescent male with bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27911098" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and Remodeling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27911098" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and Remodeling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27911098" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and Remodeling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17532848" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Duodenal appearance of giardiasis in a child with selective immunoglobulin A deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12809578" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : [Follicular lymphoid hyperplasia, IgA deficiency and coinfecction of Giardia lamblia and Epstein-Barr virus].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9711002" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : [Reactive arthritis due to Giardia lamblia in a patient with IgA deficiency].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11748158" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Central importance of immunoglobulin A in host defense against Giardia spp.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18205219" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Individuals with selective IgA deficiency resolve rotavirus disease and develop higher antibody titers (IgG, IgG1) than IgA competent individuals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19665769" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8885812" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Prevalence and diagnosis of celiac disease in IgA-deficient children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9290622" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Celiac disease and selective immunoglobulin A deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16937542" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Development of ulcerative colitis during the course of rheumatoid arthritis: Association with selective IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15307592" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Chron's disease, rare association with selective IgA immunodeficiency, and development of life-threatening bacterial infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11555120" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Crohn's disease associated with selective immunoglobulin a deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2988928" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Association of ulcerative colitis, sclerosing cholangitis and cholangiocarcinoma in a patient with IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19286327" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Nodular lymphoid hyperplasia and histologic changes mimicking celiac disease, collagenous sprue, and lymphocytic colitis in a patient with selective IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18634394" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : [Nodular lymphoid hyperplasia--underestimated problem of gastrointestinal tract pathology in children].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18217437" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Diffuse nodular lymphoid hyperplasia of the gastrointestinal tract in patient with selective immunoglobulin A deficiency and sarcoid-like syndrome--case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17301360" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : A review of gastrointestinal disorders in patients with primary antibody immunodeficiencies during a 10-year period (1990-2000), in children hospital medical center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17137841" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1114508" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Transfusion reactions associated with anti-IgA antibodies: report of four cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2052044" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : The use of intravenous immune globulin in immunodeficiency diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2450712" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with gamma-globulin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7719037" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : IgA anaphylactic transfusion reactions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15679454" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Review: IgA anaphylactic transfusion reactions. Part I. Laboratory diagnosis, incidence, and supply of IgA-deficient products.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6607511" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Anti-IgA in selective IgA deficiency. In vitro effects and Ig subclass pattern of human anti-IgA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3494039" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10798611" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11328829" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : IgA deficiency: what we should-or should not-be doing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20885296" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Anaphylactic reaction with prothrombin complex concentrate in a patient with IgA deficiency and anti-IgA antibodies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19541543" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Selective IgA deficiency in early life: association to infections and allergic diseases during childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15093556" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : IgA deficiency: clinical correlates and responses to pneumococcal vaccine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18683032" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : IgA deficiency: correlation between clinical and immunological phenotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9175025" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : IgA deficiency and SLE: prevalence in a clinic population and a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18487281" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6827588" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Systemic lupus erythematosus and IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3701176" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : [A case of systemic lupus erythematosus demonstrating basal ganglia calcifications, coronary stenosis and selective IgA deficiency].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3611910" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : [A case of 21-year-old man with selective IgA deficiency, complicated with systemic lupus erythematosus and papillary adenocarcinoma of thyroid gland].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/337537" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Epilepsy and IgA deficiency--the effect of sodium valproate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6623018" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Persistent and transient IgA deficiency in juvenile rheumatoid arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12480680" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Abnormal IgA levels in patients with rheumatoid arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23461783" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Serological testing for coeliac disease in Type 1 diabetes mellitus: is immunoglobulin A level measurement necessary?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21669464" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Concomitant autoimmunity in myasthenia gravis--lack of association with IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21125163" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Prevalence of IgA deficiency in adult systemic lupus erythematosus and the study of the association with its clinical and autoantibody profiles.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11940439" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : [Refractory idiopathic thrombocytopenic purpura and selective IgA deficiency].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25997304" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Autoimmunity in patients with selective IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7583926" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Multireactive pattern of serum autoantibodies in asymptomatic individuals with immunoglobulin A deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4099671" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Selective IgA deficiency and autoimmunity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4628164" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Anti-tissue IgG antibodies and deficiency of IgA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4632571" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Antibodies to human collagen in subjects with selective IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19127458" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15996198" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Frequent false positive beta human chorionic gonadotropin tests in immunoglobulin A deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19167929" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Familial aggregation of IgAD and autoimmunity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7318256" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Autoimmunity in selective IgA deficiency: relationship to anti-bovine protein antibodies, circulating immune complexes and clinical disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32048120" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8811056" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Development of a common variable immunodeficiency in IgA-deficient patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18520152" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Progression of selective IgA deficiency to common variable immunodeficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9357373" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Progressive immunodeficiency in a patient with IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9039524" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Conversion of selective IgA deficiency to common variable immunodeficiency in an adolescent female with 18q deletion syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8939274" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Progression of selective IgA deficiency to common variable immunodeficiency in a 16 year old boy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8804548" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Kabuki make-up syndrome associated with an acquired hypogammaglobulinemia and anti-IgA antibodies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9182895" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Age-related changes in serum immunoglobulins in patients with familial IgA deficiency and common variable immunodeficiency (CVID).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/474629" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Syndromes associated with deletion of the long arm of chromosome 18[del(18q)].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25739914" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : RAG1 deficiency may present clinically as selective IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25589342" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : IgA deficiency and risk of cancer: a population-based matched cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25370723" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Reversal of Immunoglobulin A Deficiency in Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10600329" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26371839" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Practice parameter for the diagnosis and management of primary immunodeficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35748970" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22385238" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Classification of primary immunodeficiency diseases by the International Union of Immunological Societies (IUIS) Expert Committee on Primary Immunodeficiency 2011.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8230025" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Cyclosporine A induced colitis and acquired selective IgA deficiency in a patient with juvenile chronic arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20514928" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Effect of anti-epileptic drugs on serum immunoglobulin levels in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6181216" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : The reversibility of phenytoin-induced IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3631017" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Phenytoin-induced IgA depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2631168" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Serum IgA deficiency induced by prolonged phenytoin treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10576137" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Reversible total IgA deficiency associated with phenytoin treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27396372" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : Immunoglobulin A deficiency following treatment with lamotrigine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12655433" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : IgG2, IgG4 and IgA deficiency possibly associated with carbamazepine treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9184608" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : IgA and IgG2 deficiency associated with zonisamide therapy: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2266710" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : [D-penicillamine-induced IgA deficiency in the therapy of Wilson's disease].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/314018" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : [D-penicillamin-induced IgA-deficiency (author's transl)].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/851732" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : IgA deficiency during penicillamine treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6441247" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : IgA deficiency during aurothioglucose treatment. A case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3294409" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : Selective IgA deficiency developed during treatment of scleroderma kidney with captopril.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1671461" id="rid153" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          154 : Captopril-induced IgA deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1684124" id="rid154" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          155 : Immunodeficiencies associated with sulphasalazine therapy in inflammatory arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4063627" id="rid155" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          156 : Fenclofenac-induced selective IgA deficiency in rheumatoid arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/67433" id="rid156" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          157 : Drug-induced IgA deficiency in rheumatoid arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6426644" id="rid157" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          158 : IgA deficiency during treatment of infantile hypothyroidism with thyroxine.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
